Skin : Impact Factor & More
eISSN: 2574-1624
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Skin Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | National Society for Cutaneous Medicine |
| Language | English |
| Publication Time | 4 |
| Editorial Review Process | Editorial review,Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 4 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Skin ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Skin
Gamer’s Dermatitis: When Victory Comes with a Rash
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety of Intramuscular Triamcinolone Injections for Hidradenitis Suppurativa Flares: Findings from a Retrospective Cohort Study
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Real-World Effectiveness and Safety of Nemolizumab in Moderate-to-Severe Atopic Dermatitis: A Phase IV, Prospective, Non-Interventional Study Design From RE-UNITE-AD (NCT06988605)
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Time to Efficacy Outcomes Among Biologic-Naive and -Exposed Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE REAL
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Eruptive Cutaneous Metastatic Leiomyosarcoma
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety and Adverse Events of Special Interest in 825 Adults With Atopic Dermatitis Receiving Up to 12 Months of Tralokinumab Treatment in a Real-World Setting
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Gamer’s Dermatitis: When Victory Comes with a Rash
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety of Intramuscular Triamcinolone Injections for Hidradenitis Suppurativa Flares: Findings from a Retrospective Cohort Study
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Real-World Effectiveness and Safety of Nemolizumab in Moderate-to-Severe Atopic Dermatitis: A Phase IV, Prospective, Non-Interventional Study Design From RE-UNITE-AD (NCT06988605)
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Time to Efficacy Outcomes Among Biologic-Naive and -Exposed Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE REAL
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Eruptive Cutaneous Metastatic Leiomyosarcoma
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety and Adverse Events of Special Interest in 825 Adults With Atopic Dermatitis Receiving Up to 12 Months of Tralokinumab Treatment in a Real-World Setting
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
FAQs on Skin
How many articles did Skin publish last year? 
Who is the publisher of Skin?
